Annual Operating Expenses
$154.13 M
+$12.77 M+9.03%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual total operating expenses is currently $154.13 million, with the most recent change of +$12.77 million (+9.03%) on 31 December 2023. During the last 3 years, it has risen by +$21.75 million (+16.43%). AMPH annual operating expenses is now at all-time high.AMPH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$44.89 M
+$4.94 M+12.38%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly total operating expenses is currently $44.89 million, with the most recent change of +$4.94 million (+12.38%) on 30 September 2024. Over the past year, it has increased by +$9.17 million (+25.66%). AMPH quarterly operating expenses is now at all-time high.AMPH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.0% | +25.7% |
| 3 y3 years | +16.4% | +70.0% |
| 5 y5 years | +33.3% | +36.7% |
AMPH Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +18.7% | at high | +70.0% |
| 5 y | 5 years | at high | +33.3% | at high | +70.0% |
| alltime | all time | at high | +150.3% | at high | +213.7% |
Amphastar Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.89 M(+12.4%) |
| June 2024 | - | $39.95 M(-5.1%) |
| Mar 2024 | - | $42.09 M(-0.2%) |
| Dec 2023 | $154.13 M(+9.0%) | $42.16 M(+18.0%) |
| Sept 2023 | - | $35.73 M(-0.3%) |
| June 2023 | - | $35.84 M(-11.3%) |
| Mar 2023 | - | $40.41 M(+21.2%) |
| Dec 2022 | $141.36 M(+8.9%) | $33.34 M(-5.5%) |
| Sept 2022 | - | $35.28 M(-8.4%) |
| June 2022 | - | $38.53 M(+12.6%) |
| Mar 2022 | - | $34.21 M(+7.0%) |
| Dec 2021 | $129.85 M(-1.9%) | $31.98 M(+21.1%) |
| Sept 2021 | - | $26.41 M(-28.3%) |
| June 2021 | - | $36.82 M(+6.3%) |
| Mar 2021 | - | $34.64 M(+2.0%) |
| Dec 2020 | $132.39 M(+0.3%) | $33.95 M(+2.9%) |
| Sept 2020 | - | $32.99 M(-8.6%) |
| June 2020 | - | $36.10 M(+23.0%) |
| Mar 2020 | - | $29.34 M(-12.7%) |
| Dec 2019 | $131.96 M(+14.1%) | $33.63 M(+2.4%) |
| Sept 2019 | - | $32.85 M(+4.6%) |
| June 2019 | - | $31.41 M(-7.8%) |
| Mar 2019 | - | $34.08 M(+2.8%) |
| Dec 2018 | $115.61 M | $33.14 M(+24.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2018 | - | $26.71 M(-7.9%) |
| June 2018 | - | $29.00 M(+8.4%) |
| Mar 2018 | - | $26.75 M(+20.3%) |
| Dec 2017 | $94.42 M(+6.3%) | $22.24 M(-5.4%) |
| Sept 2017 | - | $23.50 M(-4.3%) |
| June 2017 | - | $24.56 M(+2.1%) |
| Mar 2017 | - | $24.07 M(-2.9%) |
| Dec 2016 | $88.82 M(+5.4%) | $24.79 M(+13.7%) |
| Sept 2016 | - | $21.82 M(+2.0%) |
| June 2016 | - | $21.38 M(+2.7%) |
| Mar 2016 | - | $20.83 M(+10.3%) |
| Dec 2015 | $84.25 M(+21.7%) | $18.88 M(-11.5%) |
| Sept 2015 | - | $21.32 M(-9.3%) |
| June 2015 | - | $23.50 M(+14.4%) |
| Mar 2015 | - | $20.54 M(+6.2%) |
| Dec 2014 | $69.24 M(-0.1%) | $19.34 M(-1.3%) |
| Sept 2014 | - | $19.59 M(+22.6%) |
| June 2014 | - | $15.98 M(+11.7%) |
| Mar 2014 | - | $14.31 M(-13.7%) |
| Dec 2013 | $69.34 M(+10.4%) | $16.58 M(-17.3%) |
| Sept 2013 | - | $20.05 M(+29.3%) |
| June 2013 | - | $15.51 M(-9.9%) |
| Mar 2013 | - | $17.20 M |
| Dec 2012 | $62.81 M(+2.0%) | - |
| Dec 2011 | $61.58 M | - |
FAQ
- What is Amphastar Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual operating expenses year-on-year change?
- What is Amphastar Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly operating expenses year-on-year change?
What is Amphastar Pharmaceuticals annual total operating expenses?
The current annual operating expenses of AMPH is $154.13 M
What is the all time high annual operating expenses for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual total operating expenses is $154.13 M
What is Amphastar Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, AMPH annual total operating expenses has changed by +$12.77 M (+9.03%)
What is Amphastar Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of AMPH is $44.89 M
What is the all time high quarterly operating expenses for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly total operating expenses is $44.89 M
What is Amphastar Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, AMPH quarterly total operating expenses has changed by +$9.17 M (+25.66%)